TECNALIA works with nanoclusters and plans the exploitation of DeDNAed
DeDNAed partner TECNALIA is working with antibodies decorated with nanoclusters as well as nanobodies. They also lead the exploitation of the project.
Read More
IMMM characterizes nanoparticles using SERS
The Institute of Molecules and Materials of Le Mans (IMMM) is in charge of the characterization of the optical and plasmonic properties of the nanostructures included in the bioanalytical platform. It also determines the SERS efficiency and the sensing performances of the platform. Finally, it is involved in the validation of the sensor for food and biomedical applications.
CIC biomaGUNE creates plasmonic particles and sensing elements
DeDNAed partner CIC biomaGUNE is responsible for design, synthesis, and characterization of different sensing biorecognition elements (antibodies and DNA aptamers) in pure state and modified with metallic and semiconductor atomic clusters. They also design, synthesize, and provide metallic nanoparticles of different size and shape as amplifiers of optical read out signals.
TechForum Millstatt, 3-7 June 2024, Millstatt, AT
Save the date for the TechForum Millstatt which will tak place from 3 – 7 June 2024 in Millstatt, Austria.
BioCHIP 2024, 28-29 May 2024, Berlin, Germany
BioCHIP Berlin focuses on technologies and applications of microfluidic platforms, fabrication techniques, system integration and emerging applications for life sciences.
DeDNAed @ MAIN Focus Day on Quantum Dots
The MAIN research center at the Technical University of Chemnitz (TUC) hosted its MAIN Focus Day on Quantum Dots on 18 January 2024.
The event consisted of 2 research seminars held at the MAIN facilities and a colloquium in the central auditorium.
Julia Hann presented a poster showing the possibility of integrating quantum dots with the DNA origami on surfaces, using the example of our activities in nanoparticles and biomolecules with DeDNAed.
More information about the event (in German) can be found here.
DeDNAed @ BNN Quarterly (Dec 2023)
DeDNAed was featured in the latest BNN QUARTERLY issue (Dec 2023), our âDigital Magazine for Developments in Sustainable Technologyâ with an article about “DeDNAed Meeting and Interactive Training of the Consortium”.
ANTHOS 2024, 4-7 March 2024, Vienna
The âAdvanced (Nano)Materials and Technologies: science, research & innovation for safety and sustainabilityâ Summit 2024 (ANTHOS 2024) promotes the advancements in technological innovation & research results on Safe-by-Design (SbD) for advanced (nano)materials and beyond.
First Joint Publication for DeDNAed
In the field of medical diagnostics, the identification and measurement of biomarkers have become essential tools for early disease detection and treatment monitoring.
Within DeDNAed, Le Mans UniversitÃĐ (France) and the research centre TECNALIA Research & Innovation (Spain) focus their research on the detection of interleukin-6, a cytokine which can be used to monitor various human diseases and treatment responses. Conventional assays, such as ELISAs, are time-consuming and require large sample volumes. Therefore, the development of a fast, sensitive and selective detection method is critical.
Researchers from DeDNAed proposed a sensing method based on the surface-enhanced Raman scattering (#SERS), a technique that emerges as a promising alternative for the highly sensitive IL-6 detection.
They developed a label-free SERS immunoassay, achieving an impressive limit of detection of 0.91 pg mLâ1 (0.04 pM), ten times lower than ELISA. Moreover, this label-free approach offers a simple, and fast (~90 min) assay for direct IL-6 monitoring.
This study, “Label-free SERS for rapid identification of interleukin 6 based on intrinsic SERS fingerprint of antibodyâgold nanoparticles conjugate,” published in December 2023 in the International Journal of Biological Macromolecules, showcased the collaborative success between the University of Le Mans and the research centre TECNALIA thanks to authors Marjan Majdinasab, Aicha Azziz, Qiqian Liu, VerÃģnica Mora-Sanz, Nerea Briz, Mathieu Edely and Marc Lamy de la Chapelle.
Read the publication here.
General Assembly in Potsdam
From November 8-10, 2023, the DeDNAed consortium gathered for our M30 General Assembly, hosted by our partner the University of Potsdam.
The program started with work package presentations and discussion of the project’s progress, challenges and achievements. Members of our Advisory Board were present to provide valuable feedback, as well.
All partners then joined for hands-on experiments, delving deep into methodologies crucial for the development of our biosensing platform.
View some impressions from our General Assembly and group experiment here!
